PharmaEssentia
Overview
PharmaEssentia is a fully integrated global biopharmaceutical company that develops treatments for myeloproliferative neoplasms, hepatitis, and other diseases.
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances PharmaEssentia is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
PharmaEssentia holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- GEMCITABINE HYDROCHLORIDEInactive2010-10-14
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to PharmaEssentia in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this PharmaEssentia? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.